Volume 7, Issue 1, January 2017
Main Menu
DEVELOPMENT AND METHOD VALIDATION OF BICALUTAMIDE RP-HPLC IN BULK AND PHARMACEUTICAL DOSAGE FORM
Author(s): Manukondu Bhaskar, Ramya Krishna Ravuri, Ramana Hechhu, Nampelly Karnakar, Poteti Karunakar
Abstract: A simple, rapid, specific and accurate reverse phase high performance liquid chromatographic method has been developed for the validated of Bicalutamide in bulk as well as in marketed pharmaceutical dosage form. This separation was performed on a Symmetry ODS C18 (4.6×250mm, 5µm) column with Methanol: Phosphate Buffer (35:65) V/V as mobile phase at a flow rate of 1.0 mL min−1 with UV detection at 235 nm; the constant column temperature was Ambient. The runtime under these chromatographic conditions was less than 8 min. The retention time of Bicalutamide was found to be 2.252. The calibration plot was linear over the concentration range of 6–14μg mL−1 with limits of detection and quantification values of 1.2 and 3.6ng mL−1 respectively. The mean % assay of marketed formulation was found to be 99.86%, and % recovery was observed in the range of 98-102%. Relative standard deviation for the precision study was found <2%. The developed method is simple, precise, specific, accurate and rapid, making it suitable for estimation of Bicalutamide in bulk and marketed pharmaceutical dosage formdosage form.
PAGES: 179-187 | 58 VIEWS 43 DOWNLOADS
How To Cite this Article:
Manukondu Bhaskar, Ramya Krishna Ravuri, Ramana Hechhu, Nampelly Karnakar, Poteti Karunakar. DEVELOPMENT AND METHOD VALIDATION OF BICALUTAMIDE RP-HPLC IN BULK AND PHARMACEUTICAL DOSAGE FORM. 2017; 7(1): 179-187.
